Skip to main content
Symptom
dx.
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Symptom
dx.
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Get Started
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Loading...
Ventricular Escape Rhythm
Cardiovascular Presentations
Abdominal aortic aneurysm
Acute coronary syndrome (NSTEMI)
Acute coronary syndrome (STEMI)
Acute decompensated heart failure
Acute limb ischemia
Acute mesenteric ischemia
Aortic dissection
Aortic stenosis
Atrial fibrillation and flutter
Bradyarrhythmia and heart block
Cardiac arrest
Deep vein thrombosis
Myocarditis
Pericarditis
Pulmonary embolism
Stable angina
Superficial thrombophlebitis
Superior vena cava syndrome
Supraventricular tachycardia
Syncope (cardiogenic)
Unstable angina
Ventricular tachycardia
Respiratory Presentations
Acute bronchitis
Acute respiratory failure
Aspiration pneumonia
Asthma exacerbation
Bronchiolitis
Community-acquired pneumonia
COVID-19 pneumonia
COPD exacerbation
Croup
Croup (laryngotracheobronchitis)
Epiglottitis
Hemothorax
Hospital-acquired pneumonia
Pleural effusion
Pneumothorax (traumatic)
Pulmonary contusion
Spontaneous pneumothorax
Neurological Presentations
Bell's palsy
Benign paroxysmal positional vertigo
Brain abscess
Cauda equina syndrome
Cervical radiculopathy
Concussion (mild traumatic brain injury)
Encephalitis
Guillain-Barré syndrome
Hemorrhagic stroke (intracerebral)
Ischemic stroke
Lumbar radiculopathy
Malignant spinal cord compression
Migraine
Peripheral neuropathy (acute)
Retropharyngeal abscess
Schizophrenia (acute exacerbation)
Seizure (breakthrough:known epilepsy)
Seizure (first-time)
Spinal cord injury
Status epilepticus
Subarachnoid hemorrhage
Tension headache
Transient ischemic attack
Traumatic brain injury (moderate-severe)
Vestibular neuritis
Viral meningitis
Gastrointestinal Presentations
Acute appendicitis
Acute cholecystitis
Acute diverticulitis
Acute pancreatitis
Anal fissure
Choledocholithiasis and cholangitis
Clostridioides difficile colitis
Gastritis
Gastroenteritis (viral and bacterial)
Gastroesophageal reflux disease
Incarcerated or strangulated hernia
Inflammatory bowel disease flare
Large bowel obstruction
Lower GI hemorrhage
Peptic ulcer disease
Perforated viscus
Small bowel obstruction
Upper GI hemorrhage
Genitourinary and Reproductive Presentations
Acute prostatitis
Acute urinary retention
Ectopic pregnancy
Epididymitis
Orchitis
Ovarian torsion
Paraphimosis
Pelvic inflammatory disease
Priapism
Pyelonephritis
Renal laceration
Ruptured ovarian cyst
Testicular torsion
Tubo-ovarian abscess
Urinary tract infection (uncomplicated)
Urolithiasis (renal colic)
Vaginal bleeding (non-pregnant)
Infectious Disease Presentations
Acute sinusitis
Acute tonsillitis
Acute upper respiratory infection
Animal bite
Bacterial meningitis
Cellulitis
Conjunctivitis (bacterial)
Dental abscess
Endocarditis
Febrile neutropenia
Fournier gangrene
Hand-foot-mouth disease
Hepatitis (acute)
Herpes zoster
HIV-related illness
Human bite
Impetigo
Infected diabetic foot ulcer
Infectious mononucleosis
Influenza
Necrotizing fasciitis
Osteomyelitis
Otitis externa
Parasitic infection
Periorbital cellulitis
Peritonsillar abscess
Scabies
Sepsis
Septic arthritis
Spontaneous bacterial peritonitis
Tick-borne illness (Lyme disease)
Tinea infection
Tuberculosis
Viral exanthem
Wound infection
Trauma Presentations
Achilles tendon rupture
ACL and mceniscus tear
Ankle fracture
Ankle sprain
Burn
Calcaneus fracture
Cervical spine fracture
Clavicle fracture
Dental avulsion
Distal radius fracture
Drowning
Elbow fracture and dislocation
Electrical injury
Facial bone fracture
Facial laceration
Femur fracture
Fingertip amputation
Forearm fracture (radius and ulna)
Frostbite
Hand:finger laceration
Heat exhaustion
Heat stroke
Hip fracture
Humeral shaft fracture
Knee dislocation
Knee sprain
Lightning injury
Mandible fracture
Metacarpal fracture
Metatarsal fracture
Muscle strain
Nasal fracture
Non-accidental trauma
Orbital fracture
Patella fracture
Phalanx fracture (finger)
Proximal humerus fracture
Pulmonary contusion
Rib fracture
Rotator cuff tear (acute traumatic)
Scalp laceration
Scaphoid fracture
Shoulder dislocation
Skull fracture
Splenic laceration
Sternal fracture
Supracondylar pediatric fracture
Tendon laceration (hand:wrist)
Thoracic and lumbar spine fracture
Tibia:fibula fracture
Tibial plateau fracture
Toe fracture
Traumatic epistaxis
Traumatic hyphema
Toxicologic Presentations
Acetaminophen toxicity
Alcohol intoxication
Alcohol withdrawal
Anticholinergic toxicity
Anticoagulant overdose
Benzodiazepine overdose
Benzodiazepine:sedative overdose
Beta-blocker and calcium channel blocker toxicity
Carbon monoxide poisoning
Caustic ingestion
Digoxin toxicity
Drug eruption
Foreign body ingestion
Opioid intoxication
Opioid overdose
Opioid withdrawal
Organophosphate
Salicylate toxicity
Serotonin syndrome
Stimulant intoxication (cocaine, methamphetamine)
Tricyclic antidepressant overdose
Psychiatric Presentations
Acute anxiety
Acute psychosis
Agitation:behavioral emergency
Bipolar disorder
Conversion disorder
Major depressive episode
Neuroleptic malignant syndrome
Suicidal ideation and attempt
Musculoskeletal and Rheumatologic Presentations
Acute low back pain (mechanical)
Bursitis
Cervical radiculopathy
Costochondritis
Gout (acute)
Lumbar radiculopathy
Pseudogout
Tendinitis
Dermatology Presentations
Acute eczema (Eczema acute flare)
Allergic contact dermatitis
Erythema multiforme
Henoch-Schönlein purpura
Pressure injury
Psoriasis (acute flare)
Stevens-Johnson syndrome
Toxic epidermal necrolysis
Urticaria (acute)
Environmental and Exposure Presentations
Envenomation (snake, spider, insect)
High-altitude illness
Hypothermia
Hematologic and Oncologic Presentations
Acute chest syndrome
Coagulopathy
Hyperviscosity syndrome
Sickle cell crisis (vaso-occlusive)
Symptomatic anemia
Thrombocytopenia (severe)
Tumor lysis syndrome
Pediatric-Specific Presentations
Bronchiolitis
Croup
Emergency delivery
Febrile seizure
Kawasaki disease
Neonatal jaundice
Neonatal sepsis
Nursemaid's elbow
Pediatric fever 0 to 28 days
Pediatric fever 29 to 60 days
Pediatric fever 61 to 90 days
Pyloric stenosis
Slipped capital femoral epiphysis
Intussusception
Endocrine and Metabolic Presentations
Adrenal crisis
Diabetic ketoacidosis
Hypercalcemia
Hyperosmolar hyperglycemic state
Hypertensive emergency
Hypertensive urgency
Hypoglycemia
Myasthenia gravis crisis
Myxedema coma
Severe hyperkalemia
Severe hyponatremia
Thyroid storm
ENT and Maxillofacial Presentations
Acute laryngitis
Acute otitis media
Acute pharyngitis
Cerumen impaction
Epistaxis (anterior)
Nasal foreign body
Otitis externa
Tympanic membrane perforation
Ophthalmologic Presentations
Acute angle-closure glaucoma
Central retinal artery occlusion
Chemical eye injury
Corneal abrasion
Corneal ulcer
Globe rupture
Ocular foreign body
Orbital cellulitis
Retinal detachment
Obstetric Presentations
Hyperemesis gravidarum
Painful vaginal bleeding in pregnancy
Placenta previa
Placental abruption
Preeclampsia:eclampsia
Preterm labor
Threatened:inevitable:incomplete abortion
Systemic and Miscellaneous Presentations
Anaphylaxis
Angioedema
Cannabis-induced hyperemesis
Ventricular Escape Rhythm
POCUS
Procedures
Calculators
Resuscitation
ECG Guide
Back
Clinical Assessment Checklist
Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate stabilization
Airway and hemodynamic threats
▶
Hemodynamic compromise from bradycardia
▶
Heart rate 20 to 40 bpm
Systolic BP < 90 mmHg
Altered mental status from cerebral hypoperfusion
Cardiac arrest risk
▶
Asystolic pauses >= 3 seconds
Escape rate < 20 bpm
No reliable escape rhythm in 24% of complete AV block patients
If hemodynamically unstable, initiate transcutaneous pacing immediately
▶
Class I recommendation per AHA 2025 guidelines
Sedation required in conscious patients
Rhythm recognition priorities
▶
Wide QRS escape rhythm identification
▶
QRS >= 120 ms with bizarre morphology
Rate 20 to 40 bpm
AV dissociation on rhythm strip
Infranodal vs AV nodal block distinction
▶
Wide QRS = infranodal block, atropine often ineffective
Narrow QRS junctional escape = AV nodal block, atropine may help
Dangerous ECG patterns requiring immediate pacing
▶
Alternating bundle branch block morphology
QT prolongation with bradycardia and torsades risk
Monitoring and resuscitation targets
Continuous monitoring bundle
▶
Continuous cardiac monitoring with telemetry
▶
Rhythm and rate trend
Pause detection
Vital sign targets
▶
MAP >= 65 mmHg
SpO2 >= 92%
IV access and labs
▶
Two large bore IV lines
12-lead ECG stat
Escalation triggers
▶
Atropine failure criteria
▶
No rate response after 3 mg total atropine IV
Wide QRS escape with infranodal block pattern
Transcutaneous pacing bridge
▶
Failure to capture managed by pad repositioning and increased output
Sedoanalgesia for conscious patient
Temporary transvenous pacing indications
▶
Hemodynamic instability not responding to pharmacotherapy
Bridge to permanent pacemaker implantation
Immediate consults
Consultation triggers
▶
Cardiology and electrophysiology for all cases
▶
Class I indication for complete AV block pacemaker evaluation
EPS to localize block level when indicated
Critical care if ICU level care needed
▶
Vasopressor requirement
Temporary pacing management
Toxicology if drug overdose suspected
▶
Digoxin toxicity
Beta-blocker or calcium channel blocker overdose
History
Symptom presentation
Cardinal symptoms
▶
Syncope or presyncope
▶
Most critical symptom indicating hemodynamic compromise
Stokes-Adams attacks
Frequency and duration
Prodromal features
Lightheadedness and dizziness
▶
Positional relationship
Exertional trigger
Fatigue and exercise intolerance
▶
Chronotropic incompetence pattern
Functional decline timeline
Associated symptoms
▶
Dyspnea
▶
Exertional dyspnea
Orthopnea and paroxysmal nocturnal dyspnea
Chest pain
▶
Ischemic etiology consideration
ACS as trigger for AV block
Palpitations
▶
Awareness of slow rate
Irregular beat perception
Risk factor history
Cardiac history
▶
Prior myocardial infarction
▶
Inferior MI associated with AV nodal block
Anterior MI associated with infranodal block
Prior cardiac surgery or procedures
▶
TAVR associated AV block risk
Valve replacement and CABG history
Known conduction disease
▶
Prior bundle branch block
Bifascicular block history
Medication history
▶
AV nodal blocking agents
▶
Beta-blockers including ophthalmic formulations
Non-dihydropyridine calcium channel blockers including verapamil and diltiazem
Digoxin with level review
Amiodarone and sotalol and flecainide and propafenone
Other causative agents
▶
Fingolimod
Clonidine and ivabradine
Acetylcholinesterase inhibitors including donepezil
Systemic disease history
▶
Infiltrative and inflammatory disease
▶
Cardiac sarcoidosis
Cardiac amyloidosis
Autoimmune disease including SLE and rheumatoid arthritis
Infectious exposures
▶
Tick exposure and erythema migrans rash for Lyme carditis
Endemic area residence
Neuromuscular disease
▶
Myotonic dystrophy
Kearns-Sayre syndrome
Lamin A/C mutation associated muscular dystrophies
Family and collateral history
Family history
▶
Sudden cardiac death in first-degree relatives
▶
Age at death
Unexplained drowning or accident
Hereditary conduction disease
▶
Pacemaker implantation in relatives
Congenital complete heart block
Inherited cardiomyopathies
▶
Hypertrophic cardiomyopathy
Laminopathies and muscular dystrophies
Collateral history
▶
Witnessed syncopal episodes
▶
Duration of loss of consciousness
Seizure-like activity during Stokes-Adams attack
Recovery time
Medication list from pharmacy or family
▶
Complete reconciliation
Herbal supplements
Physical Exam
Vital signs and general
Hemodynamic assessment
▶
Heart rate
▶
Bradycardia 20 to 40 bpm on telemetry
Rate may rise with atropine if AV nodal block
Blood pressure
▶
Hypotension if cardiac output inadequate
Beat-to-beat variation from AV dissociation
Respiratory rate and oxygen saturation
▶
Pulmonary edema from low cardiac output
SpO2 on room air
General appearance
▶
Level of consciousness
▶
Altered mental status from cerebral hypoperfusion
Presyncope posture or pallor
Diaphoresis
▶
Hemodynamic instability marker
Cardiogenic shock sign
Cardiovascular exam
Jugular venous assessment
▶
Cannon A waves
▶
Intermittent large A waves from atrial contraction against closed tricuspid valve
Pathognomonic of AV dissociation
Elevated JVP
▶
Right heart failure from chronic bradycardia
Volume overload
Heart sounds
▶
Varying intensity of S1
▶
Hallmark of AV dissociation
Varies with PR interval relationship at each beat
Murmurs
▶
Valvular disease as etiology of AV block
Aortic stenosis TAVR association
Peripheral perfusion
▶
Varying pulse volume
▶
Beat-to-beat variation in stroke volume
Pulsus alternans if severe
Peripheral edema
▶
Biventricular failure marker
Dependent distribution
Skin and systemic exam
Skin findings
▶
Erythema migrans
▶
Lyme carditis etiology
Bull's eye rash pattern
Signs of neuromuscular disease
▶
Myotonic face
Proximal muscle wasting
Neurologic and pulmonary exam
▶
Lung auscultation
▶
Pulmonary crackles from heart failure
Pleural effusion signs
Neurologic screen
▶
Focal deficits from structural cardiac disease
Baseline cognitive status
Differential Diagnosis
Life-threatening rhythms and causes
Complete AV block etiologies
▶
Degenerative conduction system fibrosis
▶
ICD-10 I44.2 complete atrioventricular block
Most common cause in adults older than 65 years
Acute inferior MI with AV nodal block
▶
ICD-10 I21.1 ST elevation MI inferior
Usually transient with reperfusion
Acute anterior MI with infranodal block
▶
High degree block with wide QRS escape
Often requires urgent pacing
Drug-induced AV block
▶
ICD-10 T46.0 digoxin toxicity
May be drug-revealed rather than purely drug-induced
Infiltrative and inflammatory causes
▶
Cardiac sarcoidosis
▶
ICD-10 D86.85 sarcoidosis of heart
Predilection for conduction system
Cardiac amyloidosis
▶
ICD-10 E85.82 cardiac amyloidosis
Infiltration of conduction tissue
Lyme carditis
▶
ICD-10 A69.20 Lyme disease unspecified
Median resolution 6 days with range up to 42 days
Rhythm mimics
Similar wide-complex bradycardias
▶
Junctional escape rhythm
▶
Narrow QRS at 40 to 60 bpm
Higher in pacemaker hierarchy than ventricular escape
Accelerated idioventricular rhythm
▶
Rate 40 to 100 bpm
Associated with reperfusion after MI
Fusion beats and warm-up phenomenon distinguish from escape
Hyperkalemia bradycardia
▶
Peaked T waves and widened QRS
Potassium > 6.5 mmol/l
Pacemaker malfunction
▶
Failure to capture or sense in pacemaker-dependent patient
Device interrogation diagnostic
Laboratory Tests
Core metabolic and cardiac labs
Basic metabolic panel
▶
Potassium
▶
Hyperkalemia can worsen conduction disease
Target 4.0 to 5.0 mmol/l
Digoxin toxicity risk increased with hypokalemia
Calcium and magnesium
▶
Electrolyte abnormalities compound conduction disease
Hypomagnesemia risk with diuretic use
Creatinine and eGFR
▶
Drug dosing adjustment
Digoxin clearance assessment
Cardiac biomarkers
▶
Troponin
▶
ACS as cause of AV block
Serial measurements if ischemia suspected
BNP or NT-proBNP
▶
Heart failure from chronic bradycardia
Elevated with reduced cardiac output
Drug levels and targeted labs
Drug toxicity screen
▶
Digoxin level
▶
Toxic range > 2 nmol/l in adults
Toxicity causes AV block
Comprehensive medication review
▶
Beta-blocker and calcium channel blocker levels if overdose suspected
Drug-induced or drug-revealed AV block distinction
Targeted etiology labs
▶
TSH
▶
Hypothyroidism contributes to conduction disease
Treatment may reverse or improve block
Lyme serologies
▶
ELISA as screening test
Western blot confirmatory in endemic areas or suggestive history
ACE level and inflammatory markers
▶
Sarcoidosis evaluation when clinical suspicion
CRP and ESR
Anti-Ro/SSA antibodies
▶
Maternal antibodies associated with neonatal congenital complete heart block
Pediatric congenital AV block workup
Sepsis and perfusion adjuncts
Lactate
▶
Elevated with cardiogenic shock from extreme bradycardia
▶
>= 2 mmol/l suggests tissue hypoperfusion
Serial measurement to assess response to pacing
Arterial blood gas
▶
Metabolic acidosis from low cardiac output
▶
pH and base excess trending
Respiratory compensation assessment
Diagnostic Tests
Scoring Systems
Risk stratification tools for bradycardia
▶
AHA Class I pacemaker indications criteria
▶
Third-degree or advanced second-degree AV block with symptomatic bradycardia
Asymptomatic third-degree AV block with escape rate < 40 bpm
Asymptomatic third-degree AV block with infranodal escape
Asystolic pauses >= 3 seconds in awake patients
AV block requiring medically necessary drugs causing symptomatic bradycardia
JACC/HRS 2018 guideline classification
▶
Class I recommendation based on AHA/ACC/HRS evidence synthesis
High-degree and complete AV block with ventricular escape warrants pacing regardless of symptoms
Hemodynamic compromise criteria
▶
Rate < 40 bpm with hypotension or altered mentation
Cardiogenic shock pattern
Asystolic pauses with hemodynamic consequence
MRI
Cardiac MRI indications
▶
Unexplained complete AV block in younger patients
▶
Gold standard for infiltrative cardiomyopathy detection
Late gadolinium enhancement for sarcoidosis and amyloidosis
Sarcoidosis evaluation
▶
Myocardial inflammation and fibrosis characterization
Mid-wall or patchy enhancement pattern
Ischemic scar assessment
▶
Subendocardial vs transmural infarction pattern
Conduction tissue involvement
Contraindications and limitations
▶
Implanted pacemaker or ICD requiring MRI-conditional device check
▶
Device compatibility assessment mandatory
Electrophysiology team involvement
Hemodynamically unstable patient
▶
Defer until stabilized with pacing
CT
CT chest and coronary CT
▶
Coronary CT angiography
▶
Coronary artery disease evaluation as AV block etiology
Non-invasive alternative to catheterization in selected patients
Chest CT
▶
Hilar lymphadenopathy in sarcoidosis
Cardiomegaly and pulmonary congestion assessment
CT-guided workup for Lyme and other systemic causes
▶
Mediastinal lymphadenopathy
Infiltrative disease patterns
Contrast considerations
▶
Renal function review before contrast CT
▶
eGFR threshold per local protocol
Hydration pre-procedure
Ultrasound
Transthoracic echocardiography
▶
First-line imaging for all patients with ventricular escape rhythm
▶
Left ventricular function and wall motion abnormalities
Valvular disease as AV block etiology
Infiltrative pattern assessment
AV dissociation Doppler findings
▶
Beat-to-beat variation in LV filling
Variable aortic outflow tract velocities
ACEP Level B recommendation for bedside echo in hemodynamic assessment
▶
Operator-dependent limitation
Adequate for shock differentiation
Point-of-care ultrasound
▶
Hemodynamic POCUS assessment
▶
LV function gross estimate
Pericardial effusion screen
IVC assessment
▶
Volume responsiveness adjunct
Integrate with clinical exam findings
Lung ultrasound for pulmonary edema
▶
B-lines from heart failure
Assists respiratory management decisions
Disposition
Admission criteria
All ventricular escape rhythm patients require admission
▶
Mandatory continuous telemetry monitoring
▶
Rhythm change detection
Pause and asystole alert
Temporary pacing capability on unit
▶
Transcutaneous pacing at bedside
Transvenous pacing for hemodynamic instability
ICU or CCU indications
▶
Hemodynamic instability
▶
Systolic BP < 90 mmHg requiring vasopressors
Altered mental status from hypoperfusion
Active or imminent temporary pacing requirement
▶
Transcutaneous pacing in place
Awaiting transvenous pacemaker placement
Escape rate < 30 bpm or frequent asystolic pauses
▶
High arrest risk
Direct CCU monitoring
Reversible etiology observation
▶
Drug-induced AV block
▶
50% recur and ultimately require permanent pacing
Monitoring while drug clears
Lyme carditis temporary pacing
▶
Temporary pacing needed in approximately 40% of cases
Median resolution 6 days with range to 42 days
Discharge and transfer criteria
Copy
Discharge criteria
▶
Permanent pacemaker in place with appropriate function
▶
Device interrogation confirming capture and sensing
No wound complications
Reversible cause fully treated with documented AV block resolution
▶
Drug washout complete with normal conduction
Serial ECGs confirming resolution
Transfer criteria
▶
No electrophysiology capability at receiving facility
▶
Transfer to pacemaker-capable centre
Stable with transcutaneous pacing as bridge
Complex infiltrative or inflammatory etiology needing specialist centre
▶
Sarcoidosis or amyloidosis management
Multidisciplinary care coordination
Treatment
Immediate pharmacological management
Atropine
▶
First-line per AHA 2025 advanced cardiovascular life support guidelines
▶
0.5 mg IV every 3 to 5 minutes
Maximum total dose 3 mg
Class I recommendation for bradycardia with hemodynamic compromise
Limitations
▶
Often ineffective for infranodal block
Wide QRS escape with ventricular origin will not respond reliably
Do not give to heart transplant patients
Contraindications
▶
Denervated transplanted heart risk of paradoxical block or sinus arrest
Known infranodal block pattern on ECG
Catecholamine infusions for refractory bradycardia
▶
Epinephrine infusion
▶
2 to 10 mcg per minute IV infusion
Titrate to heart rate and BP response
Bridge to pacing
Dopamine infusion
▶
5 to 20 mcg per kg per minute IV infusion
Titrate to hemodynamic targets
Monitor for arrhythmia at higher doses
Isoproterenol
▶
May improve infranodal escape rates via catecholamine effect
2 to 10 mcg per minute IV infusion
Use with caution in ischemic etiology
Transcutaneous and transvenous pacing
Transcutaneous pacing
▶
Immediate bridge for hemodynamic compromise
▶
Anterior-posterior pad placement preferred for consistent capture
Start at 200 mA and adjust to minimum effective output
Electrical capture confirmed by wide QRS paced complex and pulse
Sedoanalgesia for conscious patients
▶
Midazolam 1 to 2.5 mg IV titrated
Fentanyl 1 mcg per kg IV for analgesia
Ketamine 0.5 to 1 mg per kg IV as alternative
Temporary transvenous pacing
▶
Indications
▶
Hemodynamic instability not corrected by pharmacotherapy
Bridge to permanent pacemaker implantation
Atropine failure in symptomatic patient
Procedure
▶
Right internal jugular or subclavian access preferred
Fluoroscopy or ECG guidance for lead positioning
Target rate 60 to 70 bpm initially
Monitoring post-placement
▶
Threshold testing and sensing threshold
CXR to confirm lead position and exclude pneumothorax
Definitive treatment
Permanent pacemaker implantation
▶
Class I indications from 2018 ACC/AHA/HRS Bradycardia Guidelines
▶
Third-degree or advanced second-degree AV block with symptomatic bradycardia
Asymptomatic third-degree AV block with escape rate < 40 bpm
Asymptomatic third-degree AV block with infranodal escape
Asystolic pauses >= 3 seconds in awake patients
AV block requiring medically necessary drugs causing symptomatic bradycardia
Device selection
▶
Dual-chamber pacing preferred to maintain AV synchrony
CRT if reduced ejection fraction and bundle branch block pattern
MRI-conditional device for patients likely to need future MRI
Post-implantation care
▶
Wound check at 1 to 2 weeks
Device interrogation at 1 month then every 6 to 12 months
Reversible cause treatment
▶
Digoxin toxicity
▶
Digoxin-specific Fab antibodies
Dose based on estimated total body load or empiric 10 vials
Monitor for rebound toxicity
Drug discontinuation
▶
Stop all causative AV nodal blocking agents
Monitor for 50% recurrence rate suggesting underlying conduction disease
Lyme carditis treatment
▶
Doxycycline 100 mg PO twice daily for 14 to 21 days for outpatient-managed mild cases
Ceftriaxone 2 g IV daily for hospitalized patients with high-degree block
Temporary pacing until AV block resolves
Hyperkalemia correction
▶
Calcium gluconate 10 mL of 10% solution IV for cardiac membrane stabilization
Insulin and dextrose for cellular potassium shift
Sodium bicarbonate if severe acidosis
Medications to avoid
Contraindicated drugs in ventricular escape rhythm
▶
AV nodal blockers without functioning pacemaker
▶
Verapamil and diltiazem potentially harmful in wide-complex rhythms
Beta-blockers worsen infranodal conduction
Atropine in heart transplant recipients
▶
Paradoxical sinus arrest or worsening block risk
Denervated heart does not respond normally
Special Populations
Pregnancy
Pregnancy considerations
▶
Congenital complete heart block in neonates
▶
Associated with maternal anti-Ro/SSA antibodies in neonatal lupus
Surveillance echocardiography during pregnancy in antibody-positive mothers
Acquired AV block management in pregnancy
▶
Temporary pacing preferred over pharmacotherapy when possible
Atropine relatively safe in short term for hemodynamic compromise
Pacemaker implantation in pregnancy
▶
Generally safe when indicated
Lead-free fetal radiation techniques preferred
Multidisciplinary obstetric and cardiology planning
Hemodynamic goals
▶
Maintain adequate cardiac output for uteroplacental perfusion
Left lateral decubitus positioning to improve venous return
Geriatric
Older adult specific considerations
▶
Degenerative fibrosis predominant etiology
▶
Most common cause of AV block in adults over 65 years
Lev disease fibrosis of left side of cardiac skeleton
Lenegre disease progressive fibrosis of conduction bundle
Polypharmacy and drug interactions
▶
Multiple AV nodal blocking agents more common in elderly
Renal impairment increases drug toxicity risk especially digoxin
QT prolongation risk from multiple agents
Pacemaker outcomes
▶
Older patients benefit equally from permanent pacing
Device longevity and lead revision planning
Frailty and procedural risk assessment
Atypical presentation
▶
Falls and cognitive decline may be primary presentation
Fatigue and reduced exercise tolerance without classic syncope
Baseline ECG review essential for comparison
Pediatrics
Pediatric specific considerations
▶
Congenital complete heart block
▶
Associated with maternal anti-Ro/SSA antibodies
Structural congenital heart disease association
May present in neonatal period or childhood
Post-cardiac surgery AV block
▶
Common after VSD repair and AV canal repair
Epicardial pacing wires post-operatively
Permanent pacing if block persists beyond 7 to 10 days
Weight-based pharmacotherapy
▶
Atropine 0.02 mg per kg IV minimum 0.1 mg maximum 0.5 mg per dose
Epinephrine 0.01 mg per kg IV for refractory bradycardia
Transcutaneous pacing available in pediatric sizes
Pacemaker implantation in children
▶
Epicardial leads preferred in infants and small children
Transvenous leads when patient size allows
Regular lead assessment for growth-related complications
Background
Epidemiology
Incidence and prevalence
▶
Ventricular escape rhythm as consequence of complete AV block
▶
Complete AV block prevalence approximately 0.02 to 0.04% in general population
Increases with age
Incidence increases sharply after age 70 years
Etiology distribution in adults
▶
Degenerative fibrosis accounts for majority of acquired complete AV block
Coronary artery disease second most common cause
Drug-induced AV block increasing with polypharmacy
Outcomes data
▶
24% of patients with complete AV block have no reliable escape rhythm
Mean 7 seconds to symptoms in patients without reliable escape
Infranodal escape carries higher sudden death risk than junctional escape
Pathophysiology
Pacemaker hierarchy failure
▶
Normal cardiac automaticity hierarchy
▶
Sinus node intrinsic rate 60 to 100 bpm
AV junction intrinsic rate 40 to 60 bpm
Ventricular myocardium and Purkinje fibers intrinsic rate 20 to 40 bpm
Ventricular escape activation
▶
Passively emerges when all higher pacemakers fail or are blocked
Wide QRS from abnormal ventricular activation sequence
Irregular depolarization pattern through working myocardium
AV dissociation mechanism
▶
P waves continue at sinus rate independent of QRS complexes
P-wave rate exceeds QRS rate in complete AV block
Cannon A waves from atrial contraction against closed AV valves
Anatomic localization
▶
Level of block determines escape rhythm characteristics
▶
AV nodal block produces junctional narrow QRS escape
Infranodal block below His bundle produces ventricular wide QRS escape
Infranodal block less responsive to atropine due to autonomic innervation
Prognostic significance of level
▶
Infranodal block more unpredictable and slower than AV nodal block
Higher risk for asystole and sudden cardiac death
HV interval >= 70 ms on EPS suggests infranodal disease
Therapeutic Considerations
Pharmacotherapy limitations
▶
Atropine mechanism and limitations
▶
Blocks vagal tone at AV node
Ineffective for infranodal block which lacks vagal innervation
Maximum benefit in AV nodal level block
Catecholamines as bridge
▶
Stimulate beta-1 receptors to enhance automaticity
Temporary stabilization only
Isoproterenol specifically may enhance infranodal escape rate
Pacemaker therapy evidence
▶
Permanent pacing outcomes
▶
Eliminates syncope and sudden death risk from complete AV block
Improves heart failure symptoms from chronotropic incompetence
Class I recommendation from 2018 ACC/AHA/HRS guidelines
Device optimization
▶
AV synchrony preservation improves cardiac output
Rate-responsive pacing for exercise incompetence
His bundle pacing as physiologic alternative when feasible
Reversibility considerations
▶
Drug-induced vs drug-revealed block distinction
▶
Drug-revealed block uncovers pre-existing conduction disease
50% of drug-associated AV block ultimately requires permanent pacing
Extended monitoring after drug washout recommended
Ischemic AV block
▶
Inferior MI AV block usually transient with reperfusion
Anterior MI infranodal block often permanent
Revascularization may not restore AV conduction in established block
Patient Discharge Instructions
copy discharge instructions
Copy
Ventricular escape rhythm and heart pacemaker home care
▶
Your heart has been treated for a very slow dangerous heart rhythm
A permanent pacemaker has been implanted to control your heart rate
The pacemaker keeps your heart beating at a safe rate
Pacemaker wound care
▶
Keep the incision site dry for 48 hours after implant
No scrubbing or submerging in water until fully healed
Watch for redness swelling warmth or discharge from the wound
No heavy lifting or overhead arm activity for 4 to 6 weeks on the pacemaker side
Activity restrictions
▶
No driving until cleared by your cardiologist due to syncope risk
▶
Typically 1 week minimum after pacemaker if no prior syncope
Follow provincial or state driving regulations
Avoid contact sports and magnetic resonance environments unless told safe by your doctor
No direct contact with strong magnetic fields or large electric motors
Medications
▶
Do not stop or start heart medications without your doctor's approval
Bring complete medication list to all appointments
Avoid any new medications including over the counter without checking with your doctor
Warning signs to return to ER immediately
▶
Syncope or loss of consciousness
Near-fainting or severe dizziness
Palpitations or sensation of very slow or irregular heartbeat
Chest pain or pressure
New shortness of breath at rest
Confusion or new unusual weakness
Pacemaker wound signs including redness fever or separation
Hiccups that are persistent or pacemaker pocket swelling
Follow-up plan
▶
Pacemaker wound check at 1 to 2 weeks after implant
Device interrogation at 1 month after implant
Cardiology follow-up every 6 to 12 months thereafter
If discharged without pacemaker after reversible cause treatment
▶
Cardiology follow-up within 1 to 2 weeks
Repeat ECG at follow-up visit
Contact clinic immediately if any warning symptoms return
References
Guidelines and key sources
Primary guidelines
▶
2018 ACC/AHA/HRS Guideline on Evaluation and Management of Bradycardia and Cardiac Conduction Delay
▶
Kusumoto FM et al. Heart Rhythm 2019
Journal of the American College of Cardiology 2019
2025 AHA Guidelines for CPR and Emergency Cardiovascular Care Part 9 Adult Advanced Life Support
▶
Wigginton JG et al. Circulation 2025
2012 ACCF/AHA/HRS Focused Update on Device-Based Therapy
▶
Epstein AE et al. Journal of the American College of Cardiology 2013
Drug-Induced Arrhythmias AHA Scientific Statement
▶
Tisdale JE et al. Circulation 2020
Supporting evidence
▶
Mangrum JM and DiMarco JP. Evaluation and Management of Bradycardia. NEJM 2000
Rosenheck S et al. Ventricular Escape Rhythm in Complete AV Block. Pacing and Clinical Electrophysiology 1993
Sfairopoulos D et al. Drug-Induced or Drug-Revealed AV Block. Journal of Cardiovascular Electrophysiology 2025
Aldaas OM et al. Pacemakers. NEJM Evidence 2025
Coding references
▶
ICD-10 I44.2 complete atrioventricular block
ICD-10 I44.30 unspecified atrioventricular block
SNOMED CT complete atrioventricular block disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.
← Management Protocols
Home
Management Protocols
Ventricular Escape Rhythm